Improving L-dopa therapy: the development of enzyme inhibitors.
about
Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease.Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy.Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.Levodopa: 50 years of a revolutionary drug for Parkinson disease.Synthesis of New Hydrazone Derivatives for MAO Enzymes Inhibitory Activity.
P2860
Improving L-dopa therapy: the development of enzyme inhibitors.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Improving L-dopa therapy: the development of enzyme inhibitors.
@en
type
label
Improving L-dopa therapy: the development of enzyme inhibitors.
@en
altLabel
Improvingl-dopa therapy: The development of enzyme inhibitors
@en
prefLabel
Improving L-dopa therapy: the development of enzyme inhibitors.
@en
P2860
P356
P1433
P1476
Improving L-dopa therapy: the development of enzyme inhibitors.
@en
P2860
P304
P356
10.1002/MDS.26050
P4011
3816e122533d2d43cb75337b6cb978a3de4b4137
P407
P50
P577
2014-10-21T00:00:00Z